hypogonadism; testosterone; fda; mens health

In this episode, Dr. Morgentaler and Dr. Brandon talk about the FDA finally reversing its stance on testosterone risks, what that means for heart health, and why it’s a big win for science—and for patients. Chapters 00:07 – FDA's New Stance on Testosterone In this episode, Dr. Morgentaler...

https://www.medscape.com/viewarticle/physicians-welcome-testosterone-labeling-changes-2025a10006gq?form=fpf Marius Pharmaceuticals, which markets Kyzatrex (testosterone undecanoate) capsules, indicated further studies of testosterone could be coming. Shalin Shah, CEO of the company, said in a...